Ebola: DRC gets 70,000 Ervebo vaccine doses as Bundibugyo outbreak worsens
WHO’s technical advisory group on candidate vaccine prioritisation recently recommended that Ervebo be included in a randomised clinical trial during the ongoing DRC outbreak following a review of emerging evidence on its potential cross-protection against Bundibugyo virus.
The use of Ervebo in the current outbreak could therefore serve a dual purpose; providing protection to health workers who are at high risk of exposure while generating evidence on whether an existing Ebola vaccine can provide protection against another species of the virus.
READ ALSO: DRC Ebola outbreak becomes second-largest on record – WHO Nigeria’s preparedness The continued spread of the virus has also raised concerns beyond the DRC because of the potential for cross-border transmission.
This is a summary of the original articles listed below. Always read the source articles for the full context. GhanaSummary does not create or modify the news — we summarise and link to original publishers.
